Ryan McGroarty
Known title: See RemarksCIK: 0002059196
Associated companies
Transaction History
| LFST | ▼ Sell | Tax Withholding | 24,255 | $156K | 3/24/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 47,594 | $328K | 3/17/2026 | View on chart |
| LFST | ▲ Buy | Grant | 127,878 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 50,929 | $352K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 65,168 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 25,644 | $177K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 179,856 | $0 | 3/5/2026 | View on chart |
| LFST | ▲ Buy | Grant | 184,911 | $0 | 3/24/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.